Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 46 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
20052D versus 3D radiation therapy for prostate carcinoma: A direct comparison of dose volume parametersSale, C.; Yeoh, E.; Scutter, S.; Bezak, E.
2022The use of computed tomography in the management of injury in tertiary emergency departments in Western Australia: Evidence of overtesting?Ha, N.T.; Abdullah, L.; Bulsara, M.; Celenza, A.; Doust, J.; Fatovich, D.; McRobbie, D.; Mountain, D.; O’Leary, P.; Slavotinek, J.; Wright, C.; Youens, D.; Moorin, R.
2023From Biowaste to Lab-Bench: Low-Cost Magnetic Iron Oxide Nanoparticles for RNA Extraction and SARS-CoV-2 DiagnosticsYu, L.; Adamson, P.; Lay Yap, P.; Tung, T.; Makar, S.; Turra, M.; Higgins, G.; Losic, D.
2017Nanotopography-based strategy for the precise manipulation of osteoimmunomodulation in bone regenerationChen, Z.; Bachhuka, A.; Wei, F.; Wang, X.; Liu, G.; Vasilev, K.; Xiao, Y.
2013Quo vadis radiotherapy? Technological advances and the rising problems in cancer managementAllen, B.; Bezak, E.; Marcu, L.
2006The prediction of transmitted dose distributions using a 3D treatment planning systemReich, P.; Bezak, E.; Mohammadi, M.; Fog, L.
2015PET-specific parameters and radiotracers in theoretical tumour modellingJennings, M.; Marcu, L.; Bezak, E.
2013Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of diseaseWeekley, C.; Harris, H.
2013Improving therapeutic ratio In head and neck cancer with adjuvant and cisplatin-based treatmentsMarcu, L.
2022Alzheimer’s Drug PBT2 Interacts with the Amyloid β 1–42 Peptide Differently than Other 8-Hydroxyquinoline Chelating DrugsSummers, K.L.; Roseman, G.; Schilling, K.M.; Dolgova, N.V.; Pushie, M.J.; Sokaras, D.; Kroll, T.; Harris, H.H.; Millhauser, G.L.; Pickering, I.J.; George, G.N.